DM
Deerfield Management Portfolio holdings
AUM
$5.51B
This Quarter Return
-10.64%
1 Year Return
+12.76%
3 Year Return
+152.98%
5 Year Return
+204.91%
10 Year Return
+993.1%
AUM
$2.35B
AUM Growth
+$2.35B
(-1.2%)
Cap. Flow
+$239M
Cap. Flow
% of AUM
10.19%
Top 10 Holdings %
Top 10 Hldgs %
36.4%
Holding
126
New
15
Increased
30
Reduced
16
Closed
18
Top Buys
| 1 |
AVXS
AveXis, Inc. Common Stock
AVXS
|
$60.9M |
| 2 |
Editas Medicine
EDIT
|
$59M |
| 3 |
PTLA
Portola Pharmaceuticals, Inc.
PTLA
|
$49.1M |
| 4 |
Viatris
VTRS
|
$36M |
| 5 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$34.1M |
Top Sells
| 1 |
DYAX
DYAX CORPORATION
DYAX
|
$84.3M |
| 2 |
Teva Pharmaceuticals
TEVA
|
$53.5M |
| 3 |
Charles River Laboratories
CRL
|
$30.3M |
| 4 |
GHDX
Genomic Health, Inc.
GHDX
|
$28.5M |
| 5 |
Pacira BioSciences
PCRX
|
$28.5M |
Sector Composition
| 1 | Healthcare | 69.81% |
| 2 | Financials | 4.2% |
| 3 | Technology | 0.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
HTWR
26
DELISTED
HEARTWARE INTERNATIONAL INC COM STK (DE)
HTWR
| $27.4M | 1.16% |
870,634
+710,673
| +444% | +$22.3M |
|
|
ACOR
27
DELISTED
Acorda Therapeutics, Inc.
ACOR
| $27.2M | 1.16% |
+1,029,410
| New | +$27.2M |
|
|
DBVT
28
DBV Technologies
DBVT
$249M
| $26.6M | 1.13% |
817,806
+355,937
| +77% | +$11.6M |
|
|
RLYP
29
DELISTED
RELYPSA INC COM
RLYP
| $25.4M | 1.08% |
1,873,471
+973,190
| +108% | +$13.2M |
|
|
TVTY
30
DELISTED
Tivity Health, Inc. Common Stock
TVTY
| $25M | 1.06% |
2,475,387
+10,345
| +0.4% | +$104K |
|
|
INFI
31
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
| $23.2M | 0.99% |
4,398,862
+93,574
| +2% | +$493K |
|
32
Zevra Therapeutics
ZVRA
$501M
| $20.6M | 0.88% |
1,420,497
| – | – |
|
33
Larimar Therapeutics
LRMR
$337M
| $20.4M | 0.87% |
3,055,603
+2,211,938
| +262% | +$14.8M |
|
|
SRRA
34
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
| $20.2M | 0.86% |
3,001,302
+1,210,047
| +68% | +$8.16M |
|
|
RAD
35
DELISTED
Rite Aid Corporation
RAD
| $19.5M | 0.83% |
2,393,072
-99,700
| -4% | -$813K |
|
|
GBT
36
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $18.9M | 0.81% |
1,193,811
+30,000
| +3% | +$476K |
|
37
Axogen
AXGN
$718M
| $18.1M | 0.77% |
3,381,439
| – | – |
|
|
AKTX
38
Akari Therapeutics
AKTX
$21.4M
| $16.1M | 0.69% |
1,150,700
| – | – |
|
|
ALPN
39
DELISTED
Alpine Immune Sciences, Inc. Common Stock
ALPN
| $15.6M | 0.66% |
3,732,412
| – | – |
|
40
Elevance Health
ELV
$72.4B
| $14.2M | 0.6% |
102,000
+87,351
| +596% | +$12.1M |
|
41
Galapagos
GLPG
$2.06B
| $13.7M | 0.58% |
327,626
+144,626
| +79% | +$6.05M |
|
42
Novavax
NVAX
$1.2B
| $12.7M | 0.54% |
+2,456,261
| New | +$12.7M |
|
43
Regenxbio
RGNX
$498M
| $12.6M | 0.54% |
1,169,042
| – | – |
|
|
IMPR
44
DELISTED
IMPRIVATA, INC COM
IMPR
| $12.4M | 0.53% |
983,366
-223,052
| -18% | -$2.82M |
|
45
CytomX Therapeutics
CTMX
$350M
| $12.2M | 0.52% |
943,433
-2,589
| -0.3% | -$33.4K |
|
|
ALIM
46
DELISTED
Alimera Sciences, Inc.
ALIM
| $10.3M | 0.44% |
5,878,015
| – | – |
|
47
Protara Therapeutics
TARA
$125M
| $9.79M | 0.42% |
1,265,343
| – | – |
|
48
MacroGenics
MGNX
$121M
| $9.71M | 0.41% |
517,920
| – | – |
|
|
IVTY
49
DELISTED
Invuity, Inc
IVTY
| $9.58M | 0.41% |
1,327,009
+248,791
| +23% | +$1.8M |
|
|
GI
50
DELISTED
EndoChoice Holdings, Inc.
GI
| $9.5M | 0.4% |
1,823,309
| – | – |
|